| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |